Abnormal merosin in adults: A new form of late onset muscular dystrophy not linked to chromosome 6q2

Brain

Volumn 121, Issue 4, 1998, Pages 581-588

  Bushby, K ^a   Anderson, L V B ^b   Pollitt, C ^a   Naom, I ^c   Muntoni, F ^c   Bindoff, L ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Limb girdle muscular dystrophy; Merosin; Muscle proteins

Indexed keywords

CALPAIN; CREATINE KINASE; DYSTROPHIN; MEROSIN; SARCOGLYCAN;

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME 6Q; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; FEMALE; FLEXOR MUSCLE; GASTROCNEMIUS MUSCLE; GENETIC ANALYSIS; HAMSTRING; HIP; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LEG MUSCLE; MALE; MUSCLE BIOPSY; MUSCLE HYPERTROPHY; MUSCULAR DYSTROPHY; ONSET AGE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE OF ONSET; BRAIN; CHILD; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; HUMANS; LAMININ; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUTATION; NUCLEAR FAMILY;

EID: 0031954817     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.4.581     Document Type: Article

References (33)

1. Anderson LV. Optimized protein diagnosis in the autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 1996; 6: 443-6.
2. Anon. Aids to the examination of the peripheral nervous system. London: Baillière Tindall; 1986.
3. Bashir R, Keers S, Strachan T, Passos-Bueno R, Zatz M, Weissenbach J, et al. Genetic and physical mapping at the limb-girdle muscular dystrophy locus (LGMD2B) on chromosome 2p. Genomics 1996; 33: 46-52.
4. Beckmann JS. Genetic studies and molecular structures: the dystrophin associated complex. Hum Mol Genet 1996; 5: 865-7.
5. Bejaoui K, Hirabayashi K, Hentati F, Haines JL, Ben Hamida C, Belal S, et al. Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14. Neurology 1995; 45: 768-72.
6. Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, et al. β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995; 11: 266-73.
7. Bushby KM. Towards the classification of the autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 1996; 6: 439-41.
8. Bushby KM. The limb-girdle muscular dystrophies. In: Emery AEH, editor. Diagnostic criteria for neuromuscular disorders. London: Royal Society of Medicine Press; 1997. p. 17-22.
9. Bushby KM, Beckmann JS. The limb-girdle muscular dystrophies - proposal for a new nomenclature. Neuromuscul Disord 1995; 5: 337-43.
10. Dubowitz V. Congenital muscular dystrophies. In: Emery AEH, editor. Diagnostic criteria for neuromuscular disorders. London: Royal Society of Medicine Press; 1997. p. 23-6.
11. Duggan DJ, Gorospe JR, Fanin M, Hoffman EP, Angelini C. Mutations in the sarcoglycan genes in patients with myopathy [see comments]. N Engl J Med 1997; 336: 618-24. Comment in: N Engl J Med 1997; 336: 650-1.
12. Duggan DJ, Gorospe JR, Fanin M, Hoffman EP, Angelini C. Mutations in the sarcoglycan genes in patients with myopathy [see comments]. N Engl J Med 1997; 336: 618-24. Comment in: N Engl J Med 1997; 336: 650-1.
13. Fardeau M, Hillaire D, Mignard C, Feingold N, Feingold J, Mignard D, et al. Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996; 119: 295-308.
14. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995; 11: 216-8.
15. Hillaire D, Leclerc A, Faure S, Topaloglu H, Chiannilkulchai N, Guicheney P, et al. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994; 3: 1657-61.
16. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, et al. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995; 11: 257-65.
17. Mahjneh I, Passos-Bueno MR, Zatz M, Vainzof M, Marconi G, Nashef L, et al. The phenotype of chromosome 2p-linked limb-girdle muscular dystrophy. Neuromuscul Disord 1996; 6: 483-90.
18. Naom IS, D'Allessandro M, Topaloglu H, Sewry CA, Ferlini A, Helbling-Leclerc A, et al. Refinement of the laminin α2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy. J Med Genet 1997; 34: 99-104.
19. Nicholson LV, Davison K, Falkous G, Harwood C, O'Donnell E, Slater CR, et al. Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody. J Neurol Sci 1989; 94: 125-36.
20. Nicholson LV, Johnson MA, Gardner-Medwin D, Bhattacharya S, Harris JB. Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (Berl) 1990; 80: 239-50.
21. Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB et al. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups. J Med Genet 1993; 30: 728-36.
22. Nissinen M, Helbling-Leclerc A, Zhang X, Evangelista T, Topaloglu H, Cruaud C, et al. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin α2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet 1996; 58: 1177-84.
23. Noguchi S, McNally EM, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M, et al. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy [see comments]. Science 1995; 270: 819-822.
24. Comment in: Science 1995; 270: 755-6.
25. North KN, Beggs AH. Deficiency of a skeletal muscle isoform of α-actinin (α-actinin-3) in merosin-positive congenital muscular dystrophy. Neuromuscul Disord 1996; 6: 229-35.
26. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromuscul Disord 1995; 5: 301-5.
27. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995; 81: 27-40.
28. Sewry CA, Taylor J, Anderson LVB, Ozawa E, Pogue R, Piccolo F, et al. Abnormalities in α, β and γ sarcoglycan in patients with limb-girdle muscular dystrophy. Neuromuscul Disord 1996; 6: 467-74.
29. Spencer MJ, Tidball JG, Anderson LV, Bushby KM, Harris JB, Passos-Bueno MR, et al. Absence of calpain 3 in a form of limb-girdle muscular dystrophy (LGMD2A). J Neurol Sci 1997; 146: 173-8.
30. Tan E, Topaloglu H, Sewry C, Zorlu Y, Naom I, Erdem S, et al. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency. Neuromuscul Disord 1997; 7: 85-9.
31. Tome FM, Evangelista T, Leclerc A, Sunada Y, Manole E, Estournet B, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 1994; 317: 351-7.
32. Vainzof M, Passos-Bueno MR, Canovas M, Moreira ES, Pavanello RC, Marie SK, et al. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet 1996; 5: 1963-9.
33. Wewer UM, Engvall E. Merosin/laminin-2 and muscular dystrophy. [Review]. Neuromuscul Disord 1996; 6: 409-18.